Waters, 186002436, BioSuite C18 PA-B Column, 300 Å, 3.5 µm, 2.1 mm X 250 mm, 1K - 30K, 1/pk
Catalog Number: 186002436
Send an RFQ.
Category
Pack Size1/pk
Loading…
Primarily supports legacy methods. BioSuite Peptide Analysis columns consist of two premier reversed-phase column chemistries specifically optimized for peptide mapping from simple to complicated digests. BioSuite PA Columns are available in various configurations for LC or LC-MS applications, including 250 mm lengths for ultra high resolution. These BioSuite PA-A and PA-B columns provide excellent batch-to-batch reproducibility for consistent results and are uniquely QC tested specifically for peptide mapping. BioSuite C18 3 µm PA-A is a 100Å, difunctional bonded, low ligand density, silica-based reversed-phase column and BioSuite C18 3.5 µm PA-B is a 300Å, high ligand density, monofunctional, silica-based reversed-phase column.
| Chemistry | C18 |
|---|---|
| Separation Mode | Reversed Phase |
| Particle Substrate | Silica |
| pH Range Min | 2 pH |
| pH Range Max | 8 pH |
| Maximum Pressure | 6000 psi (415 Bar) |
| Endcapped | Yes |
| Molecular Weight Range Min | 1000 |
| Molecular Weight Range Max | 30000 |
| Particle Shape | Spherical |
| Particle Size | 3.5 µm |
| Endfitting Type | Waters |
| Pore Size | 300 Å |
| Format | Column |
| BTO Flag | true |
| System | HPLC |
| USP Classification | L1 |
| Inner Diameter | 2.1 mm |
| Length | 250 mm |
| Carbon Load | 8.5 % |
| UNSPSC | 41115709 |
| Application | Peptide |
| Brand | BioSuite |
| Product Type | Columns |
| Units per Package | 1 pk |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
